Clinical Trials Directory

Trials / Completed

CompletedNCT06725069

Effects of Neuromuscular Electrical Stimulation on Flexor Spasticity and Function in Stroke Patients

Effects of Neuromuscular Electrical Stimulation Applied to Agonist or Antagonist Muscles of the Upper Extremity on Flexor Spasticity and Function in Patients With Stroke

Status
Completed
Phase
Study type
Observational
Enrollment
36 (actual)
Sponsor
Gaziler Physical Medicine and Rehabilitation Education and Research Hospital · Academic / Other
Sex
All
Age
45 Years – 75 Years
Healthy volunteers
Not accepted

Summary

In this study, the investigators aimed to determine the effects of botulinum neurotoxin type A injections for wrist and finger flexor spasticity and neuromuscular electrical stimulation therapy applied to wrist and finger flexors or extensors on upper extremity flexor spasticity and function in stroke patients.

Detailed description

Neuromuscular electrical stimulation therapy applied to wrist and finger flexors (agonist application) or wrist and finger extensors (antagonist application) after botulinum neurotoxin type A injections in stroke patients with wrist and finger flexor spasticity in upper extremity flexor spasticity, To determine the effects on motor recovery, upper extremity and hand functions, hand grip strength, range of motion, functional independence, quality of life, hand skills and sonographically evaluated muscle thickness and to compare these different applications.

Conditions

Interventions

TypeNameDescription
OTHERNeuromuscular Electrical StimulationNMES was performed using the Enraf Nonius Myomed 632X device. Both applications were performed 5 days/week for 4 weeks. NMES was performed with the patients in a sitting position and the affected arm resting on a table with the forearm supinated (Agonist group) / forearm pronated (Antagonist group). Surface electrodes (50x50 mm self-adhesive) were placed on the wrist and finger flexor/extensor muscle group. NMES parameters; Symmetric biphasic, pulse width 200 μs, on time 6 seconds (ramp up 1 second, ramp down 2 seconds), off time 12 seconds, stimulation intensity according to the patient's tolerance (not exceeding 90 mA), frequency 50 Hz and was adjusted to elicit contraction in the flexor and extensor muscles of the wrist and fingers.
OTHERControl (Standard treatment)In addition to conventional treatment, participants were included in an occupational rehabilitation program for 20 minutes to improve upper extremity functions.

Timeline

Start date
2024-02-01
Primary completion
2024-10-31
Completion
2025-01-14
First posted
2024-12-10
Last updated
2025-04-02

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06725069. Inclusion in this directory is not an endorsement.